Genomic analysis of recombinant Sabin clinical isolates

Recombination in Poliovirus vaccine strains is a very frequent phenomenon. In this report 23 polio/Sabin strains isolated from healthy vaccinees or from VAPP patients after OPV administration, were investigated in order to identify recombination sites from 2C to 3D regions of the poliovirus genome. RT-PCR, followed by Restriction Fragment Length Polymorphism (RFLP) screening analysis were applied in four distant genomic regions (5' UTR, VP1, 2C and 3C-3D) in order to detect any putative recombinant. The detected recombinants were sequenced from 2C to the end of the genome (3' UTR) and the exact recombination sites were determined with computational analysis. Five of the 23 isolated strains were recombinant in one genomic region, two of them in 2C, isolates EP16:S3/S2, EP23:S3/S1, two in 3D isolates EP6:S2/S1, EP12:S2/S1 and one in 3A isolate EP9:S2/Sl. Point mutations were found in strains EP3, EP6, EP9 and EP12. Recombination specific types and sites re-occurrence along with point mutations are discussed concerning the polioviruses evolution

Search For Poliovirus Carriers Among People With Primary Immune Deficiency Diseases In The United States, Mexico, Brazil, And The United Kingdom

Objective: To estimate the rate of long-term poliovirus excretors in people known to have B-cell immune deficiency disorders. Methods: An active search for chronic excretors was conducted among 306 persons known to have immunoglobulin G (IgG) deficiency in the United States, Mexico, Brazil, and the United Kingdom, and 40 people with IgA deficiency in the United States. Written informed consent or assent was obtained from the participants or their legal guardians, and the studies were formally approved. Stool samples were collected from participants and cultured for polioviruses. Calculation of the confidence interval for the proportion of participants with persistent poliovirus excretion was based on the binomial distribution. Findings: No individuals with long-term excretion of polioviruses were identified. Most participants had received oral poliovirus vaccine (OPV) and almost all had been exposed to household contacts who had received OPV. Polioviruses of recent vaccine origin were transiently found in four individuals in Mexico and Brazil, where OPV is recommended for all children. Conclusion: Although chronic poliovirus excretion can occur in immunodeficient persons, it appears to be rare.82138Benyesh-Melnick, M., Melnick, J.L., Rawls, W.E., Wimberly, I., Oro, J.B., Ben-Porath, E., Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter (1967) American Journal of Epidemiology, 86, pp. 112-136Melnick, J.L., Benyesh-Melnick, M., Brennan, J.C., Studies on live poliovirus vaccines. Its neurotropic activity in monkeys and its increased neurovirulence after multiplication in vaccinated children (1959) JAMA, 171, pp. 1165-1172Gelfand, H.M., Potash, L., LeBlanc, D.R., Fox, J.P., Revised preliminary report on the Louisiana observations of the natural spread within families of living vaccine strains of poliovirus (1959) Live Poliovirus Vaccines: Papers Presented and Discussions Held at the First International Conference on Live Poliovirus Vaccines, , Special Publication No. 44. Washington (DC): Pan American Sanitary BureauFox, J.P., Gelfand, H.M., LeBlanc, D.R., Potash, L., Clemmer, D.I., LaPenta, D., The spread of vaccine strains of poliovirus in the household and in the community in southern Louisiana (1961) International Poliomyelitis Congress, Ed. Poliomyelitis: Papers and Discussions Presented at the Fifth International Poliomyelitis Conference, pp. 368-383. , Philadelphia: LippincottSutter, R.W., Cochi, S.L., Melnick, J.L., Live attenuated poliovirus vaccines (1999) Vaccines, 3rd Ed., pp. 364-408. , Plotkin SA, Orenstein WA, editors. Philadelphia: WB SaundersModlin, J.F., Coxsackieviruses, echoviruses, and newer enteroviruses (2000) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 5th Ed., pp. 1904-1919. , Mandell GL, Bennett JE, Dolin R, editors. Philadelphia (PA): Churchill-LivingstoneWood, D.J., Sutter, R.W., Dowdle, W.R., Stopping poliovirus vaccination after eradication: Issues and challenges (2000) Bulletin of the World Health Organization, 78, pp. 347-357Kew, O.M., Sutter, R.W., Nottay, B.K., McDonough, M.J., Prevots, D.R., Quick, L., Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient (1998) Journal of Clinical Microbiology, 36, pp. 2893-2899Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis (2003) Journal of General Virology, 84, pp. 1215-1221John, T.J., Walker, D.H., Enterovirus infections, including poliomyelitis (1999) Tropical Infectious Diseases, Principles, Pathogens, and Practice, pp. 1123-1132. , Guerrant RL, Walker DH, Weller PF, editors. Philadelphia: Churchill LivingstoneMinor, P., Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies (2001) Developmental Biology, 105, pp. 75-80Minor, P.D., Ferguson, J.A., Icenogle, J.P., Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee (1986) Journal of General Virology, 67, pp. 693-706Dunn, G., Begg, N.T., Cammack, N., Minor, P.D., Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources (1990) Journal of Medical Virology, 32, pp. 92-95Sutter, R.W., Tangermann, R.H., Aylward, R.B., Cochi, S.L., Poliomyelitis eradication: Progress, challenges for the end game, and preparation for the post-eradication era (2001) Infectious Disease Clinics of North America, 15, pp. 41-64Conley, M.E., Notarangelo, L.D., Etzioni, A., Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and eSID (European Society for Immunodeficiencies) (1999) Clinical Immunology, 93, pp. 190-197(1997) Manual of the Virological Investigation of Poliomyelitis, , Geneva: World Health Organization. WHO document WHO/EPI/GEN/9701Liu, H.M., Zheng, D.P., Zhang, L.B., Oberste, M.S., Pallansch, M.A., Kew, O.M., Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China (2000) Journal of Virology, 74, pp. 11153-11161Savilahti, E., Klemola, T., Carlsson, B., Mellander, L., Stenvik, M., Hovi, T., Inadequacy of mucosal IgM antibodies in selective IgA deficiency excretion of attenuated polio viruses is prolonged (1988) Journal of Clinical Immunology, 8, pp. 89-94Triki, H., Barbouche, M.R., Bahri, O., Bejaoui, M., Dellagi, K., Community-acquired poliovirus infection in children with primary immunodeficiency in Tunisia (2003) Journal of Clinical Microbiology, 41, pp. 1203-1211Hammon, W.D., Coriell, L.L., Wehrle, P.F., Stokes, J., Evaluation of Red Cross gammaglobulin as a prophylactic agent for poliomyelitis. 4. Final report of results based on clinical diagnosis (1953) JAMA, 151, pp. 1272-1285Halliday, E., Winkelstein, J., Webster, A.D., Enteroviral infections in primary immunodeficiency (PID): A survey of morbidity and mortality (2003) The Journal of Infection, 46, pp. 1-8Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis (2003) Journal of General Virology, 84, pp. 1215-1221Cunningham-Rundles, C., Bodian, C., Common variable immunodeficiency: Clinical and immunological features of 248 patients (1999) Clinical Immunology, 92, pp. 34-48Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus (2002) Science, 296, pp. 356-359Halsey, N.A., Commentary: Poliomyelitis and unnecessary injections (2003) International Journal of Epidemiology, 32, pp. 278-279Halsey, N.A., Combination vaccines: Defining and addressing current safety concerns (2001) Clinical Infectious Diseases, 33 (SUPPL. 4), pp. S312-S31